Paylocity reported total revenues of $451.7 million for the quarter ended September 30, 2026, representing a 10.7% increase year-over-year. Net income rose to $57.6 million compared to $48.0 million in the prior year period, while the company significantly increased its share repurchase activity, spending $152.5 million during the quarter.
Eastern Bankshares, Inc. reported net income of $111.0 million for the third quarter of 2026, up from $106.1 million in the prior year period, driven by a significant increase in net interest income. Total assets grew to $31.7 billion as of September 30, 2026, while the company continued its capital return strategy through $57.2 million in common stock repurchases during the quarter.
Mettler-Toledo reported a 6% increase in total net sales to $1.09 billion for the third quarter of 2026, with net earnings rising to $246.0 million ($12.29 per diluted share). For the nine months ended September 30, 2026, the company generated $648.3 million in net earnings and continued its aggressive share repurchase program, spending $638.7 million to buy back common stock during the period.
Triton International Limited reported net income of $140.8 million for the third quarter of 2026, an increase from $117.3 million in the prior year period. Total revenues decreased to $285.8 million from $333.8 million year-over-year, primarily driven by lower operating lease revenues, though this was partially offset by a significant net gain on the sale of leasing equipment.
Teradata reported total revenue of $399 million for the third quarter of 2026, a slight decrease from $416 million in the prior year. However, net income for the first nine months of 2026 surged to $419 million compared to $93 million in 2025, primarily driven by a significant $469 million gain in other income.
Under Armour reported a net revenue of $2.34 billion for the six months ended September 30, 2026, a decrease from $2.47 billion in the prior year. Despite the revenue decline, the company achieved a slight net income of $120 thousand compared to a net loss of $21.4 million in the same period last year, primarily driven by lower restructuring charges and improved gross margins.
Dogwood Therapeutics reported a net loss of $21.4 million for the nine months ended September 30, 2026, which included a $9.2 million impairment charge related to IPR&D. The company ended the period with $4.9 million in cash and cash equivalents, down from $6.5 million at the end of 2025.
National HealthCare Corporation reported Q3 2026 net operating revenues of $408.0 million, a 6.6% increase year-over-year. Adjusted net income rose 13.8% to $28.2 million, primarily driven by the recent acquisition of 35 real estate assets from National Health Investors and five additional skilled nursing facilities.
Texas Roadhouse reported total revenue of $1.57 billion for the 13 weeks ended September 29, 2026, with net income attributable to the company rising to $89.4 million compared to $83.2 million in the prior year period. The company maintained a strong balance sheet with $3.69 billion in total assets and declared cash dividends of $0.75 per share for the quarter.
Norwood Financial Corp reported net income of $11.8 million for the third quarter of 2026, up from $8.3 million in the prior year period, driven by higher net interest income following the acquisition of PB Bankshares, Inc. Total assets grew to $2.95 billion as of September 30, 2026, while the company incurred $5.0 million in merger-related expenses during the first nine months of the year.
Minerva Neurosciences reported third quarter 2026 financial results and provided a business update on its ongoing Phase 3 trial (C19 Study) of roluperidone for negative symptoms of schizophrenia. The company expects topline efficacy data from Phase A of the trial in the second half of 2027 and remains focused on developing non-dopaminergic treatments for CNS disorders.
Term
Q3 2026
“The psychiatry field has increasingly recognized the importance of finding non-dopaminergic mechanisms in the treatment of schizophrenia, particularly for negative symptoms. Roluperidone is the only late-stage candidate targeting negative symptoms directly. The C19 study, our ongoing Phase 3 trial, is designed to confirm the effect we saw in our prior trials. We remain focused on execution and on track for topline efficacy data in the second half of 2027.”
Remy Luthringer, Ph.D., Chief Executive Officer of Minerva Neurosciences
Elanco Animal Health reported revenue of $1,265 million for the third quarter of 2026, an increase from $1,137 million in the prior year. The company achieved a net income of $18 million for the quarter, recovering from a net loss of $34 million in Q3 2025, driven by higher gross profits and lower restructuring charges.
Farmers National Banc Corp. reported net income of $53.8 million for the first nine months of 2026, up from $39.9 million in the prior year, driven by a significant increase in net interest income following a business combination. Total assets grew to $7.1 billion as of September 30, 2026, while the company recorded a substantial unrealized loss on available-for-sale securities of $74.6 million net of tax during the period.
For the nine months ended September 30, 2026, Immunocore reported total revenue of $324.8 million, a 10% increase over the prior year, and a significantly narrowed net loss of $2.1 million compared to $5.5 million in 2025. The company maintained a strong liquidity position with $901.3 million in cash, cash equivalents, and marketable securities.
Immunocore reported Q3 2026 financial results with KIMMTRAK net revenues of $102.2 million and a net loss of $14.2 million. The company highlighted the completion of target enrollment for its Phase 3 TEBE-AM trial in cutaneous melanoma and the first patient dosed in its autoimmune program for type 1 diabetes.
Term
Q3 2026
“Nearly five years after launch, KIMMTRAK remains the proven standard of care in HLA-A*02:01+ metastatic uveal melanoma. With TEBE-AM fully enrolled and data expected in the second quarter of 2027, we are advancing our mission to bring this therapy to even more patients.”
Bahija Jallal, CEO of Immunocore
“Recently, our platform delivered two significant firsts: what we believe is the first data demonstrating clinical activity and a manageable safety profile with the combination of two T cell engagers in a solid tumor, and the first patient dosed in our tissue-specific autoimmune program for type 1 diabetes.”
First Financial Bancorp reported net income of $81.2 million for the third quarter of 2026, up from $71.9 million in the prior year period. Total assets grew to $22.3 billion, driven by a 3.6% increase in total loans and leases since year-end 2025, while net interest income for the first nine months of 2026 rose significantly to $576.2 million.
United Bancorp reported Q3 2026 net income of $1.4 million, or $0.25 per diluted share, which was negatively impacted by a $2.95 million commercial credit charge-off. Despite this one-time event, the company noted that its Pre-Provision Net Revenue (PPNR) increased year-over-year to $3.49 million, driven by investments in infrastructure and growth.
Term
Q3 2026
“During the three-month period ended September 30, 2026, we were impacted by a one-time event that caused earnings to perform below our typical expectations. For the most recently ended quarter, United Bancorp, Inc. (UBCP) produced net income and diluted earnings per share of $1,401,000 and $0.25, respectively.”
Randall M. Greenwood, Senior Vice President, CFO and Treasurer
“Fundamentally and exclusive of the one-time loan charge off experienced this most recent quarter, we are very satisfied with the level at which UBCP is presently performing and firmly believe that the initiatives our Company has undertaken in the last two years are paying off.”
Randall M. Greenwood, Senior Vice President, CFO and Treasurer
Protagonist Therapeutics reported a significant increase in license and collaboration revenue to $544.3 million for the nine months ended September 30, 2026, resulting in a net income of $386.6 million compared to a net loss in the prior year. The company's cash position strengthened considerably, with total assets reaching $1.15 billion as of the end of the third quarter.
Green Plains Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $186.2 million compared to a net loss of $133.9 million in the prior year period. This improvement was driven by a substantial reduction in cost of goods sold and a sharp increase in production tax credits, which rose to $209.9 million.
XPEL, Inc. reported a 9.9% increase in total revenue to $137.8 million for the third quarter of 2026, with net income attributable to stockholders rising to $16.3 million. The company significantly increased its property and equipment assets to $95.1 million and took on $42.6 million in long-term debt to support its growth and acquisition strategies.
John Marshall Bancorp reported net income of $7.5 million for the quarter ended September 30, 2026, an increase from $5.4 million in the prior year period. Total assets grew to $2.44 billion, driven by a $92.0 million increase in total deposits and steady loan growth during the first nine months of the year.
CG Oncology reported a net loss of $196.1 million for the first nine months of 2026, driven by a significant increase in research and development expenses to $137.6 million. The company strengthened its balance sheet through a follow-on public offering that raised $391.6 million, ending the period with over $984 million in cash and marketable securities.
Forrester Research reported a net loss of $4.4 million for the third quarter of 2026, with total revenues declining to $86.1 million from $94.3 million in the prior year period. The company's nine-month performance was impacted by a $10.8 million goodwill impairment charge, though this was significantly lower than the $83.9 million impairment recorded in the same period of 2025.
For the nine months ended September 30, 2026, Assured Guaranty Ltd. reported net income attributable to the company of $205 million, a decrease from $384 million in the prior year period. Total assets grew to $12.4 billion, while the company expanded its operations through the acquisition of Assured Life Re and the introduction of annuity reinsurance segments.
First Citizens BancShares reported net income of $606 million for the third quarter of 2026, with total assets reaching $241.2 billion. The company experienced a significant increase in total deposits to $185.3 billion, while net interest income saw a slight decrease compared to the prior year's quarter.
Plains GP Holdings reported third-quarter 2026 net income of $363 million and Adjusted EBITDA of $711 million. The company highlighted the expansion of its Permian JV gathering system and the $585 million acquisition of the Silver Creek gathering system in the Powder River Basin. Management reaffirmed full-year 2026 Adjusted EBITDA guidance of approximately $2.88 billion.
Term
Q3 2026
“Our company delivered solid operational performance year-to-date with continued execution across the organization on our key initiatives for the year. We are driving efficient growth through multiple avenues including a further expansion of our Permian gathering footprint to service additional acreage in the Midland Basin with a large integrated producer.”
Willie Chiang, Chairman, CEO and President
“The recent junior subordinated notes offering and corresponding redemption of preferred securities is expected to generate distributable cash flow accretion to common unitholders. Finally, the oil macro environment remains volatile, yet constructive, and we see multiple tailwinds for our business as we build momentum into 2027.”
Plains All American reported third-quarter 2026 net income of $363 million and Adjusted EBITDA of $711 million. The company highlighted the completion of its $585 million acquisition of Silver Creek assets and a new Permian JV gathering expansion supported by a 10-year agreement with a large integrated producer. Management reaffirmed full-year 2026 Adjusted EBITDA guidance of approximately $2.88 billion.
Term
Q3 2026
“Our company delivered solid operational performance year-to-date with continued execution across the organization on our key initiatives for the year. We are driving efficient growth through multiple avenues including a further expansion of our Permian gathering footprint to service additional acreage in the Midland Basin with a large integrated producer.”
Willie Chiang, Chairman, CEO and President
“The recent junior subordinated notes offering and corresponding redemption of preferred securities is expected to generate distributable cash flow accretion to common unitholders. Finally, the oil macro environment remains volatile, yet constructive, and we see multiple tailwinds for our business as we build momentum into 2027.”
Franklin Templeton reported preliminary Q4 2026 net income of $380.1 million and full-year net income of $1.08 billion, a significant increase from the prior year. The company achieved record assets under management (AUM) of $1.8 trillion, driven by $84.1 billion in full-year long-term net inflows across all regions and channels.
Term
FY2026
“Franklin Templeton delivered strong fourth quarter and fiscal year 2026 results, reflecting the momentum across our business and continued execution of our strategy. We generated $20.8 billion in long-term net inflows during the fourth quarter, bringing full-year long-term net inflows to $84.1 billion, with positive net flows in every quarter this fiscal year across all regions and in both retail and institutional channels.”
Jenny Johnson, Chief Executive Officer of Franklin Templeton, Inc.
Community Trust Bancorp, Inc. reported its financial results for the third quarter of 2026, showing stable net interest margins and continued growth in its loan portfolio. The company maintained strong capital ratios and asset quality, though it noted slight increases in non-interest expenses related to technology investments.
DarkHorse Technologies reported Q3 2026 results, highlighting a doubling of its contracted power capacity to 100 MW following a new 50 MW agreement in Kentucky. The company is pivoting its strategy toward AI inference infrastructure and 'superintelligence factories' while completing Bitdeer mining installations across three sites.
Term
3 years
“We doubled our contracted power capacity to approximately 100 MW, completed Bitdeer installations across three sites and advanced engineering for our planned superintelligence factories, including an initial basis-of-design package for a Kentucky project and boundary surveys at two of our Kentucky development sites.”
Joel Block, Chief Executive Officer of DarkHorse
“We believe the race in AI infrastructure is to bring usable compute capacity online in 2027. Our focus is inference, where trained AI models serve everyday applications.”